Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Advanced Head and Neck Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically and cytologically confirmed diagnosis of squamous cell carcinoma.~* Patients not amenable to curative treatments with further surgery and/or radiation.~* Patient has failed treatment with chemotherapy~* Lesions must be distinct and the minimum measurements must be at least 2.0 cm x 2.0 cm at baseline.~* Karnofsky performance rating of at lest 50%.~Exclusion Criteria:~* Patients with severe and unstable cardiovascular disease.~* Treatment naive subjects will not be included for study.~* Patients with poorly controlled diabetes, seizure disorder, primary CNS tumors or known brain metastases will be excluded.~* Pregnant or nursing women.~* Patients requiring antibiotics in the preceding 2 weeks for a serious infection are not eligible.~* Patients with a fever \> 37.8 degrees C.~* Pulse \< 60 or \> 110~* Systolic blood pressure \> 170 or less than 90 are not eligible.~* Patients with nasopharyngeal squamous cell carcinoma will be excluded~* Patients with hypercalcemia will be excluded from this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single Arm (Type: EXPERIMENTAL): Opioid Growth Factor (OGF)

Based on this trial design, predict the completion outcome and termination type (if applicable).